Cardiovascular risk: its assessment in clinical practice

被引:0
|
作者
Wilson, SL
Poulter, NR
机构
[1] Barts & London Hosp, William Harvey Res Inst, London EC1M 6BQ, England
[2] Imperial Coll Sch Med, Dept Clin Pharmacol, Cardiovasc Studies Unit, London W2 1PG, England
关键词
cardiovascular system; Framingham equation; risk assessment; risk factors;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Cardiovascular disease is one of the major causes of mortality and morbidity in Western industrialised countries. Many factors impact on the likelihood of an individual suffering a stroke or heart attack. One of the greatest challenges facing clinicians today is how best to identify those individuals at increased risk, to prevent them becoming tomorrow's patients. Risk assessment tools can provide useful frameworks to support the identification of individuals who may benefit from therapeutic intervention: however, such tools should be used with care, as they do not include all the factors that contribute to future disease risk, and they are subject to an age bias. Nonetheless, they provide a systematic, evidence-based approach to the delivery of preventative healthcare services.
引用
收藏
页码:248 / 251
页数:4
相关论文
共 50 条
  • [31] An assessment of risk perception in relation to food allergy, and its relation to clinical practice, in primary care practice nurses
    Naim, S.
    Emmanuel, J.
    Hanna, H.
    Boyle, R. J.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2013, 43 (12): : 1470 - 1470
  • [32] Cardiovascular absolute risk assessment A research journey in general practice
    Zwar, Nicholas
    Harris, Mark F.
    Denney-Wilson, Elizabeth
    AUSTRALIAN FAMILY PHYSICIAN, 2011, 40 (05) : 309 - 309
  • [33] Genetic aspects of diabetes and its cardiovascular complications:: Contribution of genetics to risk assessment and clinical management
    St-Pierre, J
    Vohl, MC
    Després, JP
    Gaudet, D
    Poirier, P
    CANADIAN JOURNAL OF CARDIOLOGY, 2005, 21 (02) : 199 - 209
  • [34] A Clinical Interpretable Approach Applied to Cardiovascular Risk Assessment
    Paredes, S.
    Henriques, J.
    Rochar, T.
    Mendes, D.
    Carvalho, P.
    Moraisl, J.
    Bianchi, A.
    Salcedof, V
    2018 40TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2018, : 3252 - 3255
  • [35] Implementing Cardiovascular Risk Prediction in Clinical Practice: The Future Is Now
    Karmali, Kunal N.
    Lloyd-Jones, Donald M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (04):
  • [36] Nonsteroidal antiinflammatory drugs and cardiovascular risk: Implications for clinical practice
    Fernandez-Liz, Eladio
    Romero Suau, Maria Rosa
    ATENCION PRIMARIA, 2014, 46 (07): : 323 - 325
  • [37] The relevance of competing risk adjustment in cardiovascular risk prediction models for clinical practice
    Hageman, Steven H. J.
    Dorresteijn, Jannick A. N.
    Pennells, Lisa
    van Smeden, Maarten
    Bots, Michiel L.
    Di Angelantonio, Emanuele
    Visseren, Frank L. J.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 30 (16) : 1741 - 1747
  • [38] Osteoporosis Screening and Fracture Risk Assessment Tool: Its Scope and Role in General Clinical Practice
    Chavda, Sumant
    Chavda, Bharti
    Dube, Rajani
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (07)
  • [39] Estimating Cardiovascular Risk in Spain by the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice
    Jesus Amor, Antonio
    Masana, Luis
    Soriguer, Federico
    Goday, Albert
    Calle-Pascual, Alfonso
    Gaztambide, Sonia
    Rojo-Martinez, Gemma
    Valdes, Sergio
    Gomis, Ramon
    Ortega, Emilio
    REVISTA ESPANOLA DE CARDIOLOGIA, 2015, 68 (05): : 417 - 425
  • [40] Cardiovascular risk and the implications for clinical practice of cardiovascular outcome trials in type 2 diabetes
    Chilton, Robert J.
    Dungan, Kathleen M.
    Shubrook, Jay H.
    Umpierrez, Guillermo E.
    PRIMARY CARE DIABETES, 2020, 14 (03) : 193 - 212